As discussed above, residue 2 of TIMP interacts with the
S19 pocket of MMPs (Gomis-Ruth et al. 1997; FernandezCatalan et al. 1998; Iyer et al. 2007; Maskos et al. 2007) and has a major influence on affinity for different MMPs. Substitution of Thr2 by glycine, which has no side chain, increases the Ki value of the N-TIMP-1 and -3 for MMP- 1, MMP-2, MMP-3, and MT1-MMP by at least two to three orders of magnitude (Table 1; Meng et al. 1999; Wei et al. 2005). However, the same mutation has small effects on the inhibitory activity of N-TIMP-3 for ADAM17/TACE (Wei et al. 2005). Here, we find that this mutation in TIMP-1 has a much smaller ;20-fold effect on the inhibition of MMP-7 and MMP-9 (Table 1). In contrast to N-TIMP-1 and other mutants described above, which have similar Ki values for MMP-2 and MMP-9 (Table 1), the T2G mutant has a >2500-fold higher affinity for MMP-9 relative to MMP-2, showing that TIMP-1 can be engineered to select between the two gelatinases. Similar results were obtained with N-TIMP-3 (data not shown), suggesting that the T2G mutation may have similar effects on activity in all TIMPs. Combination with the AB2 mutation did not improve the selectivity, since the AB2 loop generally increased the affinity for those enzymes that are poorly inhibited by the T2G mutant but not on the inhibition of MMP-7 or MMP-9 A comparison of the Ki values for mutants with the AB2 loop substitution plus other mutations with those calculated by adding together their effects on the free energy of binding (Table 1) shows that some combinations have synergistic rather than additive effects. Most notably, the AB2 loop mitigates the effect of the T2G and T2R mutation on binding to certain MMPs. In the case of the T2G mutant this compensation is particularly strong for MMP-1, -2, and -3 inhibition while, for the T2R mutant, MMP-3, MMP-7, and MMP-9 are most affected.